Special protein helps maintain an efficient brainMay 19, 2009MADISON - The instruction manual for maintaining an efficient brain may soon include a section on synaptotagmin-IV (Syt-IV), a protein known to influence learning and memory, thanks to a study by University of Wisconsin-Madison researchers. The study showed that Syt-IV keeps the strength of synapses - connections between nerve cells where communication occurs - within a useful range of neither too strong nor too weak. Synapses' ability to adjust over time by becoming bigger and stronger or smaller and weaker - their plasticity - is at the heart of remembering, forgetting and learning. A delicate balance is required for this optimal brain plasticity. The study appears in Nature Neuroscience's advanced online publication on May 17. The findings may be useful in the future for treating neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease as well as epileptic seizures. Early stages of these disorders may stem from synaptic deficits. "If a drug or genetic treatment could be designed to control Syt-IV expression and modify its effect on other key players involved in synaptic function, synapses might work better," says senior author Edwin R. Chapman, a Howard Hughes Medical Institute professor at the UW-Madison School of Medicine and Public Health (SMPH). Camin Dean, a postdoctoral fellow in Chapman's physiology department laboratory at the SMPH, did most of the work on the study. The scientists have been studying synaptotagmins for several years, making great strides in understanding their role in releasing neurotransmitters and neuropeptides at both the sending and receiving sides of the synapse. The team is particularly interested in the way neurotransmitter-filled sacs, or vesicles, work at the nerve terminals. In exploring Syt-IV, known for fluctuating up and down during the course of a typical day, the researchers first studied it in a cell culture and then in mice in which the protein had been knocked out. These animals usually show learning deficits. "We quickly found that Syt-IV strongly affects multiple aspects of signal transmission, both pre- and post-synaptically," says Chapman, adding that the protein was not located where it was expected to be. The researchers also performed standard experiments on the mice to test a phenomenon called long-term potentiation (LTP), the primary synapse-strengthening mechanism that promotes learning and memory. "When we stimulate brain pathways heavily with this experiment, we see that synapses are reinforced and produce bigger responses," says Chapman. "The synapses remember the stimulation, they learn something from it and we can see evidence of that." Despite having learning disabilities, the Syt-IV-free mice produced improved LTP. In fact, it was too high. "If synapses are tweaked to the max, as they were in this case, they lose plasticity and don't work well," says Chapman. "The overload also can lead to seizures." The researchers believe that Syt-IV serves as a way to maintain synaptic homeostasis - or internal equilibrium - by reigning in LTP to a normal level. The protein does its work indirectly by regulating brain-derived neurotrophic factor (BDNF), a growth factor essential for long-term nerve cell well-being. In recent years, BDNF also has been shown to affect synapses. In the experiments, Syt-IV pulled down elevated LTP by restricting the release of BDNF on the receiving side of the synapse, gearing down synaptic activity. "Syt-IV dynamically regulates LTP as it goes up and down, holding the activity in balance," he says. "For plasticity, you need a good dynamic range of synaptic activity - from low to high." University of Wisconsin-Madison |
|||||||||||||||||||||
| Related Synapses Current Events and Synapses News Articles Clinical tests begin on medication to correct Fragile X defect NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. This is your brain on fatty acids Saturated fats have a deservedly bad reputation, but Johns Hopkins scientists have discovered that a sticky lipid occurring naturally at high levels in the brain may help us memorize grandma's recipe for cinnamon buns, as well as recall how, decades ago, she served them up steaming from the oven. APP -- Good, bad or both? New data about amyloid precursor protein, or APP, a protein implicated in development of Alzheimer's disease, suggests it also may have a positive role -- directly affecting learning and memory during brain development. University of the Basque Country study on proteins related to Alzheimer The cause, or at least one of the possible causes, of memory loss amongst Alzheimer sufferers is related to the location of certain proteins. Popular antidepressant associated with a dramatic increase in suicidal thoughts amongst men Nortriptyline has been found to cause a ten-fold increase in suicidal thoughts in men when compared to its competitor escitalopram. These findings are published in the open access journal BMC Medicine. Stanford scientist's new findings of autism-associated synapse alterations lead to coveted NIH grant A Stanford University School of Medicine researcher has pinpointed the mechanism by which a gene associated with both autism and schizophrenia influences behavior in mice. And just recently, he received a $1.65 million government grant to expand his efforts to include many more such genes. Study pinpoints key mechanism in brain development, raising question about use of antiseizure drug Researchers at the Stanford University School of Medicine have identified a key molecular player in guiding the formation of synapses - the all-important connections between nerve cells - in the brain. 1 small step for neurons, 1 giant leap for nerve cell repair The repair of damaged nerve cells is a major problem in medicine today. A new study by researchers at the Montreal NeurologicaI Institute and Hospital (The Neuro) and McGill University, is a significant advance towards a solution for neuronal repair. Researchers find a key mechanism in the development of nerve cells Chaos brews in the brains of newborns: the nerve cells are still bound only loosely to each other. Oleocanthal may help prevent, treat Alzheimer's Oleocanthal, a naturally-occurring compound found in extra-virgin olive oil, alters the structure of neurotoxic proteins believed to contribute to the debilitating effects of Alzheimer's disease. This structural change impedes the proteins' ability to damage brain nerve cells. More Synapses Current Events and Synapses News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||